TELA Bio (TELA) Accumulated Expenses (2018 - 2026)

TELA Bio's Accumulated Expenses history runs 9 years deep, the most recent figure standing at $13.9 million for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 11.21% year-over-year to $13.9 million; the TTM figure through Mar 2026 stood at $13.9 million (up 11.21% YoY), while the FY2025 annual figure was $7.1 million, down 47.25% from the prior year.
• Accumulated Expenses was $13.9 million for Q1 2026 at TELA Bio, up from $7.1 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $15.3 million in Q4 2023 to a low of $3.0 million in Q1 2022.
• Historically, Accumulated Expenses has averaged $10.2 million across 5 years, with a median of $10.8 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Accumulated Expenses soared 205.01% in 2023, then slumped 47.25% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $6.4 million in 2022, then surged by 138.32% to $15.3 million in 2023, then slipped by 12.08% to $13.5 million in 2024, then tumbled by 47.25% to $7.1 million in 2025, then surged by 96.43% to $13.9 million in 2026.
• The last three Accumulated Expenses figures came in at $13.9 million (Q1 2026), $7.1 million (Q4 2025), and $14.6 million (Q3 2025), per Business Quant data.